Dr. Dale Bredesen talks about his most recent New York Times bestselling book: The End of Alzheimer’s Program and his protocol for preventing and reversing cognitive decline. He discusses the steps to enhancing cognitive ability at any age. We will also hear an inspiring story from someone who followed Dr. Bredesen’s protocol and experienced life altering results.
Dale Bredesen is a neuroscientist who has researched neurodegenerative diseases for over thirty years. His career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible.
Dr. Bredesen earned his MD from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF), before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO. He is currently on the faculty in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles and is Chief Science Officer at Apollo Health.
Dr. Dale Bredesen talks about his most recent New York Times bestselling book: The End of Alzheimer’s Program and his protocol for preventing and reversing cognitive decline. He discusses the steps to enhancing cognitive ability at any age. We will also hear an inspiring story from someone who followed Dr. Bredesen’s protocol and experienced life altering results.
Dale Bredesen is a neuroscientist who has researched neurodegenerative diseases for over thirty years. His career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible.
Dr. Bredesen earned his MD from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF), before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO. He is currently on the faculty in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles and is Chief Science Officer at Apollo Health.